InflaRx (IFRX) received a Nasdaq notice of non-compliance with the minimum bid price and listing rules, creating potential delisting risk. This regulatory compliance issue is a negative near-term catalyst for the stock and should be monitored for any announced cure plan or other measures to regain compliance.
InflaRx (IFRX) received a Nasdaq notice of non-compliance with the minimum bid price and listing rules, creating potential delisting risk. This regulatory compliance issue is a negative near-term catalyst for the stock and should be monitored for any announced cure plan or other measures to regain compliance.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
mildly negative
Sentiment Score
-0.30
Ticker Sentiment
